← Leaderboards
Ralph J Bernacki
Roswell Park Cancer Institute Corp
$629,993
Attributed
$629,993
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$629,993 · 2
By mechanism
R01$629,993 · 1
P30$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Allan R Oseroff$3,139,346
- Maria R Baer$1,593,414
- Carl W Porter$5,047,582
- Richard B Bankert$9,763,302
- Maria L Avantaggiati$6,905,214
Others in their field
Top investigators on “Antineoplastics”
- David Heimbrook · Leidos Biomedical Research, Inc.$245,744,647
- Leonard Freedman · Leidos Biomedical Research, Inc.$243,278,693
- Charles A Coltman · Southwest Oncology Group$134,454,243
- Gregory H Reaman · National Childhood Cancer Foundation$112,139,479
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,166,869
- Richard L Schilsky · University Of Chicago$90,728,118
Research focus
AntineoplasticsDrug Design /Synthesis /ProductionDrug Screening /EvaluationNeoplasm /Cancer PharmacologyDogsLaboratory MouseHuman TissueLaboratory RatBiomedical FacilityDisease /Disorder ModelNeoplasm /Cancer TransplantationNonhuman Therapy EvaluationPaclitaxelP GlycoproteinAnalogPharmacokineticsAthymic MouseBinding SitesCell Growth RegulationCell LineChemical Structure FunctionCombination ChemotherapyDoxorubicinMultidrug Resistance